Search

Search Constraints

You searched for: Author/Creator Lenzo, Felicia L.

Search Results

1. Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity. (1st January 2020)

3. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. Issue 1 (24th January 2019)

4. PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab. (2nd December 2018)

5. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. Issue 1 (9th May 2018)

6. Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. Issue 1 (1st February 2019)

7. Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. (1st January 2020)

8. Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. (1st January 2020)